Gates Package — page 1375
of 1375 pages
← p.1374 · this page in the original PDF · package
COARPA) UCD TA2: Transmissible Vaccine for Lassa Virus
+
Generated a scalable, species-specific cytomegalovirus (CMV)-based transmissible vaccine for Lassa
virus (LASV) with internal off switch
Isolation of MasCMV
MasCMV(LASV)
MasCMV{LASV) Vaccination
yaccine construction
e
7X
LASV Antigen
Co
Intrinsic attenuation technology
L] LASV antigen gene
Flunlany
repeats
Approved
for Public Release, Dstnbuton United
Potential Vaccine Deployment Regions -- UCD Sierra Leonne, Guinea and other
countries in West Africa
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/1375
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00646 | — | attachment | 1375 |